ER patients favor CT; will tolerate radiation risk
Nearly three-quarters (74%) of emergency department patients consider diagnosis with CT more important than any associated radiation risk, according to a survey at Thomas Jefferson University Hospital in Philadelphia.
Nearly three-quarters (74%) of emergency department patients consider diagnosis with CT more important than any associated radiation risk, according to a survey at Thomas Jefferson University Hospital in Philadelphia. However, more than two-thirds (68%) of patients prefer the ordering physician to discuss the risks and benefits of CT with them before ordering the test.
The survey included 383 emergency department patients. Seventy-nine percent of patients correctly estimated their risk of cancer from chest x-rays as none, small, or very small. Eighty-three percent correctly estimated their risk of cancer from CT scans as none, small, or very small.
The researchers found differences in knowledge of radiation stratified by age, race, education, insurance status, and pain.
“Our results suggest we may help emergency department patients better with targeted teaching about radiation, decreasing their pain, discussing risks and benefits, and asking them to participate in the ordering of their diagnostic tests,” the authors said.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
